Showing results 340 to 359 of 370
< previous
next >
| Issue Date | Title | Author(s) |
| - | Targeting LIN28: a new hope in prostate cancer theranostics | Shrivastava, G; Aljabali, AAA; Shahcheraghi, SH; Lotfi, M; Shastri, MD; Shukla, SD; Chellappan, DK; Jha, NK; Anand, K; Dureja, H; Pabari, RM; Mishra, V; Almutary, AG; Alnuqaydan, AM; Charbe, N; Prasher, P; Negi, P; Goyal, R; Dua, K; Gupta, G; Serrano-Aroca, Á; Bahar, B; Barh, D; Panda, PK; Takayama, K; Lundstorm, K; McCarron, P; Bakshi, H; Tambuwala, MM |
| 2018-12 | Targeting microRNAs using nanotechnology in pulmonary diseases. | Dua, K; Chellappan, DK; Singhvi, G; de Jesus Andreoli Pinto, T; Gupta, G; Hansbro, PM |
| 2022-08 | Targeting mucus barrier in respiratory diseases by chemically modified advanced delivery systems | Prasher, P; Sharma, M; Singh, SK; Gulati, M; Jha, NK; Gupta, PK; Gupta, G; Chellappan, DK; Zacconi, F; de Jesus Andreoli Pinto, T; Chan, Y; Liu, G; Paudel, K; Hansbro, PM; George Oliver, BG; Dua, K |
| 2020-01-01 | Targeting neutrophils using novel drug delivery systems in chronic respiratory diseases | Chellappan, DK; Yee, LW; Xuan, KY; Kunalan, K; Rou, LC; Jean, LS; Ying, LY; Wie, LX; Chellian, J; Mehta, M; Satija, S; Singh, SK; Gulati, M; Dureja, H; Da Silva, MW; Tambuwala, MM; Gupta, G; Paudel, KR; Wadhwa, R; Hansbro, PM; Dua, K |
| 2020-09-24 | Targeting respiratory diseases using miRNA inhibitor based nanotherapeutics: Current status and future perspectives. | Mehta, M; Satija, S; Paudel, KR; Malyla, V; Kannaujiya, VK; Chellappan, DK; Bebawy, M; Hansbro, PM; Wich, PR; Dua, K |
| 2021-09-25 | Tea (Catechins Including (−)-Epigallocatechin-3-gallate) and Cancer | Devkota, HP; Adhikari-Devkota, A; Paudel, KR; Panth, N; Chellappan, DK; Hansbro, P; Dua, K; Jafari, SM; Nabavi, SM; Silva, AS |
| 2024-02 | The application of nanoparticles as advanced drug delivery systems in Attenuating COPD | Jessamine, V; Mehndiratta, S; De Rubis, G; Paudel, KR; Shetty, S; Suares, D; Chellappan, DK; Oliver, BG; Hansbro, PM; Dua, K |
| - | The FBXW7‐NOTCH interactome : A ubiquitin proteasomal system‐induced crosstalk modulating oncogenic transformation in human tissues | Kar, R; Jha, SK; Ojha, S; Sharma, A; Dholpuria, S; Raju, VSR; Prasher, P; Chellappan, DK; Gupta, G; Singh, S; Paudel, KR; Hansbro, PM; Singh, S; Ruokolainen, J; Kesari, KK; Dua, K; Jha, NK |
| 2023 | The Overview of Drugs Used in Alzheimer’s Disease and Their Molecular Targets | Vishwas, S; Gulati, M; Babu, MR; Awasthi, A; Kumar, R; Khursheed, R; Corrie, L; Chaitanya, MVNL; Gupta, G; Devkota, HP; Chellappan, DK; Baghel, DS; Singh, S; Dua, K; Singh, SK |
| 2016 | The Protective Action of the Aqueous Extract of Auricularia polytricha in Paracetamol Induced Hepatotoxicity in Rats. | Chellappan, DK; Ganasen, S; Batumalai, S; Candasamy, M; Krishnappa, P; Dua, K; Chellian, J; Gupta, G |
| 2023-02-06 | The versatility of 18β-glycyrrhetinic acid in attenuating pulmonary inflammatory disorders | Mohamad, MSB; Reyes, R-J; De Rubis, G; Paudel, KR; Hansbro, P; Dua, K; Chellappan, DK |
| - | The viral capsid as novel nanomaterials for drug delivery | Aljabali, AAA; Hassan, SS; Pabari, RM; Shahcheraghi, SH; Mishra, V; Charbe, NB; Chellappan, DK; Dureja, H; Gupta, G; Almutary, AG; Alnuqaydan, AM; Verma, SK; Panda, PK; Mishra, YK; Serrano-Aroca, Á; Dua, K; Uversky, VN; Redwan, EM; Bahar, B; Bhatia, A; Negi, P; Goyal, R; McCarron, P; Bakshi, HA; Tambuwala, MM |
| 2019-01-01 | Therapeutic potential of artemisia vulgaris: An insight into underlying immunological mechanisms | Soon, L; Ng, PQ; Chellian, J; Madheswaran, T; Panneerselvam, J; Gupta, G; Nammi, S; Hansbro, N; Hsu, A; Dureja, H; Mehta, M; Satija, S; Hansbro, PM; Dua, K; Collet, T; Chellappan, DK |
| 2021-06-08 | Therapeutic Potential of Phytoconstituents in Management of Alzheimer’s Disease | Singh, AK; Rai, SN; Maurya, A; Mishra, G; Awasthi, R; Shakya, A; Chellappan, DK; Dua, K; Vamanu, E; Chaudhary, SK; Singh, MP |
| 2019-10-01 | The therapeutic potential of the labdane diterpenoid forskolin | Salehi, B; Staniak, M; Czopek, K; Stepień, A; Dua, K; Wadhwa, R; Chellappan, DK; Sytar, O; Brestic, M; Bhat, NG; Kumar, NVA; Contreras, MDM; Sharopov, F; Cho, WC; Sharifi-Rad, J |
| 2023-11 | Transform diabetes care with precision medicine | Kannan, S; Chellappan, DK; Kow, CS; Ramachandram, DS; Pandey, M; Mayuren, J; Dua, K; Candasamy, M |
| - | Treatment of chronic airway diseases using nutraceuticals: Mechanistic insight | Allam, VSRR; Chellappan, DK; Jha, NK; Shastri, MD; Gupta, G; Shukla, SD; Singh, SK; Sunkara, K; Chitranshi, N; Gupta, V; Wich, PR; MacLoughlin, R; Oliver, BGG; Wernersson, S; Pejler, G; Dua, K |
| 2022-08-05 | Treatment strategies for HIV infection with emphasis on role of CRISPR/Cas9 gene: Success so far and road ahead. | Jena, R; Vishwas, S; Kumar, R; Kaur, J; Khursheed, R; Gulati, M; Singh, TG; Vanathi, BM; Alam, A; Kumar, B; Chaitanya, MVNL; Gupta, S; Negi, P; Pandey, NK; Bhatt, S; Gupta, G; Chellappan, DK; Oliver, BG; Dua, K; Singh, SK |
| 2018-03-01 | Tumor suppressor role of miR-503 | Gupta, G; Chellappan, DK; De Jesus Andreoli Pinto, T; Hansbro, PM; Bebawy, M; Dua, K |
| - | Unraveling the role of glial cell line–derived neurotrophic factor in the treatment of Parkinson’s disease | Kakoty, V; Sarathlal, KC; Kaur, P; Wadhwa, P; Vishwas, S; Khan, FR; Alhazmi, AYM; Almasoudi, HH; Gupta, G; Chellappan, DK; Paudel, KR; Kumar, D; Dua, K; Singh, SK |
